Stay updated on Arbaclofen in Children and Adolescents With ASD Clinical Trial
Sign up to get notified when there's something new on the Arbaclofen in Children and Adolescents With ASD Clinical Trial page.

Latest updates to the Arbaclofen in Children and Adolescents With ASD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, signaling a minor update to the page or site hosting rather than a change to the study data.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page shows a new revision label, v3.5.3, replacing the previous v3.5.2. This indicates a minor update to the study record without altering its content or functionality.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision: v3.5.2 was added, replacing the previous v3.5.0 on the page.SummaryDifference0.0%

- Check78 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a metadata/version update with no changes to study content or public information.SummaryDifference0.0%

- Check85 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check113 days agoChange DetectedAdded a publication entry for the AIMS-2-TRIALS-CT1 study (EClinicalMedicine, 2026) under Publications, and included revision note v3.4.2.SummaryDifference0.4%

Stay in the know with updates to Arbaclofen in Children and Adolescents With ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arbaclofen in Children and Adolescents With ASD Clinical Trial page.